Boston Biotech Nova Anchora Raises $23 Million for Topical Collagen VII Gel
Boston biotech Nova Anchora raised $23 million led by Viking Global to advance NvA-021, a topical collagen VII gel for dystrophic epidermolysis bullosa.
World News, Politics and War, Reported from Boston
Boston biotech Nova Anchora raised $23 million led by Viking Global to advance NvA-021, a topical collagen VII gel for dystrophic epidermolysis bullosa.
Boston’s Lazarus AI raised $43 million to expand enterprise AI that runs on customer hardware without per-token charges, backed by QBE, State Farm Ventures and others.
The Boston Report Briefing: a free weekly email with five important stories, election updates, local data and our latest investigations.